The Clinical Research of Cervical Chuna Treatment’s Effects on Bell’s Palsy

Article information

Acupunct. 2014;31(3):45-55
Publication date (electronic) : 2014 September 20
doi : https://doi.org/10.13045/acupunct.2014042
1Department of Acupuncture & Moxibustion Meridian & Acupoint, College of Korean Medicine, Dong-Eui University
2Samse Korean Medicine Hospital
*Corresponding author : Department of Acupuncture & Moxibustion Meridian & Acupoint, College of Korean Medicine, Dong-Eui University, 62, Yangjeong-ro, Busanjin-gu, Busan, 614-851, Republic of Korea, Tel : +82-51-850-8934, E-mail : 3rdmed@hanmail.net
Received 2014 July 03; Revised 2014 August 28; Accepted 2014 September 01.

Abstract

Objectives :

The purpose of this study is to investigate the effect of cervical Chuna treatment for Bell’s palsy.

Methods :

We investigated 30 patients with Bell’s palsy who had visited at Department of Acupuncture & Moxibustion, of Korean Medicine Hospital Dong-Eui University from June 1st, 2013 to April 15th, 2014. Subjects were randomly divided into two groups. Group A (experimental group) was treated by Korean-Western combination treatment with Cervical Chuna treatment and group B (control group) was treated by Korean-Western combination treatment without it. The cervical Chuna treatment was done twice a week, for a total of 8 times. We evaluated the change of each group by using Yanagihara’s unweighed grading system.

Results :

Yanagihara’s score in group A was significantly improved during each period from the first visit to four weeks later. However, Yanagihara’s score in group B was significantly improved except during first week. The improvement of Yanagihara’s score in group A is higher than group B during every period. And significant differences were shown after two weeks from the first visit between the two groups.

Conclusions :

These results suggest that cervical Chuna treatment may be effective for Bell’s palsy.

Fig. 1.

Flow chart

Herbal Medicine Prescription

Yanagihara’s Unweighed Grading System

General Characteristics

Distribution of Cause

Distribution of Accompanied Symptoms at Onset

The Average of Y-score in Each Group

Improvement of Y-score in Each Group During Period of Treatment

Comparison of Group A and Group B about the Improvement of Y-score

Notes

This research was supported by the Dong-Eui University Research Fund in 2014 (2014AA067)

References

1. Choi IS. Steps to internal medicine neurology Seoul: Jeongdam; 2008. p. 99–103.
2. Beak MK. The newest Otolaryngology Seoul: Ilmoongak; 1997. p. 121–7.
3. National Teacher Training Center For Health Personnel Family medicine Seoul : Seoul National University Press; 2001. p. 519–24.
4. Lindsay Kenneth W, Bone Ian. Neurology and neurosurgery illustrated Seoul: E-public. 2006. p. 222–8.
5. Yang YG. Spiritual pivot Taebuk: Taeyeonguk-pungchulpansa; 1976. p. 164–5.
6. Jang JG. Jingyue’s complete works Seoul: Seongbosa; 1982. p. 30–1.
7. Jeong GJ. Treatise on causes and symptoms of diseases Bukgyeong: Inminwisaengchulpansa; 1994. p. 11.
8. Yang GJ. Great compendium of acupuncture and moxibustion Seoul: Jeongdam; 1993. p. 416.
9. Wang EG. Correction on the errors of medical works Seoul: Iljungsa; 1992. p. 77.
10. Jin E. Treatise on the three catagories of pathogenic factors and prescriptions Bukgyeong: Inminwisaengchulpansa; 1983. p. 223.
11. Department of Acupuncture & Moxibustion Meridian & Acupoint, College of Korean Medicine Chimguhak ha Seoul: Jipmoondang; 1994. p. 1296–7.
12. Oh HJ, Song HS. Effect of cupping complex therapy on peripheral facial paralysis. J Kor Acupunc & Moxibus 2011;28(4):119–25.
13. An BJ, Song HS. Effects of electroacupuncture on patients with peripheral facial paralysis. J Kor Acupunc & Moxibus 2005;22(4):121–9.
14. Lee CW, Kim HG, Heo SW, et al. The clinical study about hominis placenta herbal acupuncture on bell’s palsy. Journal of Pharmacopuncture 2005;8(3):87–97.
15. Kang EK, Kim JH, Seo HS. The clinical investigation studies in peripheral facial paralysis using needle-embedding therapy. The Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology 2009;22(2):118–27.
16. Korean Society of Chuna Manual Medicine for Spine & Nerve. Chuna manual medicine Seoul: Korean Society of Chuna Manual Medicine for Spine & Nerve; 2013. p. 3–4. p. 171–86.
17. Park JH, Lee CH, Lee YH, et al. The clinical research of the effectiveness of “Danmuji Anchu traction technique” on acute peripheral facial paralysis. The Journal of Korea Chuna Manual Medicine for Spine & Nerves 2011;6(1):43–52.
18. Upledger John E, Vrendevoogd Jon D. Craniosacral therapy Seoul: Korean Society of Chuna Manual Medicine for Spine & Nerve; 2006. p. 70–4.
19. Yanagihara N. Grading of facial palsy. In facial nerve surgery, Zurich, 1976 In : Fisch U, ed. Amstelveen, Netherlands: Kugler Medical Publications. Birmingham, Al: Aesculapius Publishing Co; 1977. p. 533–5.
20. Seoul National University College of Medicine. Neurology Seoul: Seoul National University Press; 2006. p. 19.
21. Min YG, Choi JG, Kim RS. Ear nose throat Seoul: Ilchokak; 2000. p. 414–5.
22. Kim HD. Neurology & Neurosurgery Seoul: Koonja; 2008. p. 46p. 266–9.
23. Finsterer J. Management of peripheral facial nerve palsy. Eur Arch Otorhinolaryngol 2008;265(7):743–52.
24. The Korean Academy of Family Medicine. Textbook of family medicine Seoul: Hankookbook; 2007. p. 1010–3.
25. No GT. Otolaryngology Seoul: Ilchokak; 2002. p. 169–74.
26. Peitersen E. Bell’s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol 2002;549:4–30.
27. Yin CS, Kang MK, Kim JD, et al. Cross-sectional observation of the sequelae of peripheral facial palsy. J Kor Acupunc & Moxibus 2003;20(3):24–33.
28. Kim GW. Sa-am acupuncture therapy Susangnok Chungnam: Chorakdang; 2011. p. 225.
29. Jeong YG, Kim MY, Kim JS, et al. The domestic trend of Chuna manual therapy on cervical spinal disorders. The Journal of Korea Chuna Manual Medicine for Spine & Nerves 2013;8(1):1–13.
30. Park IB, Kim SW, Lee CW, et al. Comparative clinical study between oriental medicine and oriental-western medicine treatment on Bell’s palsy. J Kor Acupunc & Moxibus 2004;21(5):191–203.
31. Lee CH, Ku JY, Park JA, et al. Comparison of the efficacy between method of regulating ascending kidney water and descending heart fire and sweet bee venom pharmacopuncture on peripheral facial paralysis. J Kor Acupunc & Moxibus 2011;28(4):85–92.
32. Park JH, Jang JH, Lee CH, et al. The clinical research of the effectiveness of pharmacopuncture complex therapy on peripheral facial paralysis. J Kor Acupunc & Moxibus 2010;27(2):79–87.
33. Neumann Donald A. Kinesiology of the Musculoskeletal System Seoul: Jungdammedia; 2010. p. 301.
34. Thomas FB, David HP. Chiropractic technique principles and procedures Seoul: Korean Society of Chuna Manual Medicine for Spine & Nerve; 2011. p. 197–202.
35. Yang P, Song RG, Oh BP, Jang GY. Ganmyeong-gyeongnodaboneukchoseonghak Jeongju: Hanamuigwadaehakchulpansa; 1997. p. 91p. 163–7.
36. Shin BC, Kim DH, Kim SD, Song YS. Influence on vertebral artery and basilar artery blood flow by cervical Chuna manual therapy. Journal of Korea Chuna Manual Medicine 2000;1(1):45–53.
37. Paoletti Serge. The fasciae Seoul: Hanmi Medical Publishing Co; 2012. p. 103. p. 219. p. 283.
38. Seo HK, Han JM, Lee DH. The effects of myofascial release therapy on blood velocity of cranial arteryin tension type headache subjects. The Journal of Korean Academy of Orthopedic Manual Physical Therapy 2002;8(2):5–17.

Article information Continued

Fig. 1.

Flow chart

Table 1.

Herbal Medicine Prescription

Igigeopung decoction Saposhnikovia radix Paeoniae radix alba Angelicae Dahunricae Radix Citri reticulatae viride pericarpium Cnidii rhizoma Gastrodiae Rhizoma Angelicae pubescentis radix Ostericii radix Platycodi radix Glycyrrhizae Radix Schizonepetae spica Aurantii fructus Citri pericarpium Arisamatis rhizoma Linderae radix 5 g, Aconiti koreani tuber Bombyx batryticatus 4 g
Geopung decoction Polygoni multiflori radix 8 g, Citri pericarpium Lycii fructus Coicis semen Acori graminei rhizoma 6 g, Angelicae Dahunricae Radix Atractylodis rhizoma Cnidii rhizoma Angelicae gigantis radix Arisamatis rhizoma Clematidis radix Zingiberis rhizoma crudus 4 g, Aconiti koreani tuber Glycyrrhizae Radix Cimicifugae Rhizoma 2 g
Ikgi decoction Astragali radix Ginseng radix Atractylodis rhizoma white Angelicae gigantis radix Rehmanniae radix preparat Cnidii rhizoma Paeoniae radix alba Citri pericarpium Poris Glycyrrhizae Radix 6 g, Glycyrrhizae Radix Saposhnikovia radix Bupleuri radix Cimicifugae Rhizoma 4 g

Table 2.

Yanagihara’s Unweighed Grading System

Scale of rating Scale of three rating
1. At rest 0 1 2 3 4 0 2 4
2. Wrinkle forehead 0 1 2 3 4 0 2 4
3. Blink 0 1 2 3 4 0 2 4
4. Closure of eye lightly 0 1 2 3 4 0 2 4
5. Closure of eye tightly 0 1 2 3 4 0 2 4
6. Closure of eye on involved side only 0 1 2 3 4 0 2 4
7. Wrinkle nose 0 1 2 3 4 0 2 4
8. Whistle 0 1 2 3 4 0 2 4
9. Grin 0 1 2 3 4 0 2 4
10. Depress lower lip 0 1 2 3 4 0 2 4

Table 3.

General Characteristics

Group A (n=15) Group B (n=15) p-value
Age 41.53±12.00 49.40±12.15 0.085*
Sex (male/female) 15 (10/5) 15 (8/7) 0.456**
Left/right 7/8 8/7 1.000**
ENoG 54.40±19.26 44.13±20.86 0.172*
Y-score 11.93±3.35 12.80±5.49 0.606*

Values represent number or mean±standard deviation.

*

using Mann-Whitney U test, p>0.05.

**

using Chi-square test, p>0.05.

Table 4.

Distribution of Cause

Cause Group A (%) Group B (%) Total (%)
Overwork 1 (6.7) 2 (13.3) 3 (10.0)
Stress 0 (0.0) 1 (6.7) 1 (3.3)
Coldness 1 (6.7) 1 (6.7) 2 (6.7)
Overwork + stress 9 (60.0) 8 (53.3) 17 (56.7)
Overwork + coldness 0 (0.0) 0 (0.0) 0 (0.0)
Stress + coldness 0 (0.0) 0 (0.0) 0 (0.0)
Overwork + stress + coldness 3 (20.0) 3 (20.0) 6 (20.0)
Unknown 1 (6.7) 0 (0.0) 1 (3.3)
Total 15 (100.0) 15 (100.0) 30 (100.0)

Values represent number.

Table 5.

Distribution of Accompanied Symptoms at Onset

Symptom Group A Group B Total
Postauricular pain 13 14 27
Lacrimation 10 11 21
Scheroma 7 7 14
Dysgeusia 6 4 10
Hyperacusis 2 1 3
Tinnitus 1 1 2
Dizziness 1 0 1
Cold 2 3 5
No symptom 0 0 0

Values represent number.

Table 6.

The Average of Y-score in Each Group

Group A Group B
P0 11.93±3.35 12.80±5.49
P1 17.00±8.41 14.67±7.35
P2 23.33±8.75 18.13±9.75
P3 28.67±8.51 21.67±10.68
P4 32.93±7.82 24.67±11.48

P0 : score at first visit.

P1 : score after one week from visit.

P2 : score after two weeks from visit.

P3 : score after three weeks from visit.

P4 : score after four weeks from visit.

Values represent mean±standard deviation.

Table 7.

Improvement of Y-score in Each Group During Period of Treatment

Group A Group B
Z or t p-value Z or t p-value
P01 −2.772 0.006* 1.374 0.191
P12 5.491 0.000** 3.070 0.008**
P23 5.474 0.000** 3.885 0.002**
P34 4.522 0.000** 3.674 0.003**
P02 5.715 0.000** −2.267 0.023*
P03 8.591 0.000** −3.328 0.001*
P04 12.636 0.000** 4.822 0.000**

P01 : period from the first visit to one week later.

P12 : period from the one week later to two weeks later.

P23 : period from the two weeks later to three weeks later.

P34 : period from the three weeks later to four weeks later.

P02 : period from the first visit to two weeks later.

P03 : period from the first visit to three weeks later.

P04 : period from the first visit to four weeks later.

*

p-value < 0.05 by Wilcoxon signed rank test.

**

p-value < 0.05 by paired t-test.

Table 8.

Comparison of Group A and Group B about the Improvement of Y-score

Group A Group B Z or t p-value
P01 5.07±6.79 1.87±5.26 1.443 0.160
P12 6.33±4.47 3.47±4.37 1.776 0.087
P23 5.33±3.77 3.53±3.52 1.350 0.188
P34 4.27±3.65 3.00±3.16 1.015 0.319
P02 11.40±7.73 5.33±7.86 −2.513 0.011*
P03 16.73±7.55 8.87±8.59 −2.492 0.011*
P04 21.00±6.44 11.87±9.53 3.076 0.005**

P01 : period from the first visit to one week later.

P12 : period from the one week later to two weeks later.

P23 : period from the two weeks later to three weeks later.

P34 : period from the three weeks later to four weeks later.

P02 : period from the first visit to two weeks later.

P03 : period from the first visit to three weeks later.

P04 : period from the first visit to four weeks later.

Values represent mean±standard deviation.

* :

p-value < 0.05 by Mann-Whitney U test.

**

p-value < 0.05 by Student’s t-test.